Intuitive Machines’ Q2 2024: Revenue Soars, Future Brightby Mark Eisenberg 17.08.2024Intuitive Machines sees revenue doubling in Q2 2024, forecasting $210-240M full-year, with key mission progress.
Navigating an Oversold Market: Key Strategiesby Mark Eisenberg 15.08.2024Experts discuss 'oversold' markets and strategies to navigate upcoming stock turbulence amid economic volatility.
India’s Trade Deficit Widens in July Amid Export Slumpby Mark Eisenberg 15.08.2024India's trade deficit in July hit $23.5 billion, driven by weak exports, raising concerns over global economic resilience.
Preparing for New U.S. Biotech Legislationby Lilu Anderson 15.08.2024Companies must adapt as U.S. advances biotech bill restricting Chinese suppliers.
Profit from Real Estate Investing with REITsby Mark Eisenberg 15.08.2024Explore how REITs offer investment opportunities in real estate, ensuring regular income and capital appreciation.
Top Biotech ETFs for Diversificationby Lilu Anderson 15.08.2024Explore top biotech ETFs like XBI, BBH, and IBB, offering potential returns and portfolio diversification in a growing market.
Berkshire Hathaway’s Bold Moves in Latest Portfolioby Mark Eisenberg 15.08.2024Discover how Buffett's firm reshapes its holdings with new investments in Ulta and others, sparking market excitement.
Alexis Ohanian’s Investment Triumphs and Regretsby Mark Eisenberg 15.08.2024Reddit cofounder Alexis Ohanian shares his best investments and costly financial missteps in a candid podcast interview.
Universal IRA Transforms Retirement Investingby Mark Eisenberg 14.08.2024Equity Trust's Universal IRA offers flexibility with traditional and alternative asset investments.
Meiji Yasuda Acquires Allstate’s Voluntary Benefitsby Mark Eisenberg 14.08.2024Japan's Meiji Yasuda buys Allstate's business for $2B to boost global profits by 2027.